Clarivate Analytics Plc (CLVT) Stock Price, Quote & News

Company Profile

Clarivate Plc operates as an information services provider in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. The company provides scientific and academic research, a connect data, solutions, and expertise so that research institutions can thrive; ProQuest One solutions provide access to multidisciplinary curated content across a variety of formats including data...

Industry: Information Technology Services

Sector: Technology

Phone: 44 20 7433 4000

Website: www.clarivate.com

Address:

70 St. Mary Axe, London, United Kingdom

briefingcom Aug. 27 at 1:02 PM

$CLVT: Clarivate selected by Sinopec for impactful research and innovation https://www.briefing.com/in-depth-analysis/Content/Article?ArticleId=IN20250827042515CLVT&utm_campaign=inplay&utm_medium=social&utm_source=st&utm_content=view_page

0 · Reply

Thestocktraderhubzee Aug. 27 at 10:02 AM

WATCHLIST AUG 27 2025 $FLY Firefly Aerospace Receives FAA Clearance To Resume Alpha Rocket Launches After Flight 6 Investigation; Determining Next Launch Window For Alpha Flight 7 $CLVT Clarivate Signs Agreements To Provide Sinopec Group With Academic Research And Intellectual Property Solutions Empowering R&D Goals $KO Fanta Teams Up With Universal Pictures And Blumhouse To Unite Horror Icons In First Global Halloween Partnership With Limited-Edition Flavor $NCNO Piper Sandler Maintains Neutral on Ncino, Raises Price Target to $34 $CTRI Centuri Holdings Secures $300M U.S. Awards Across Northeast, Southeast, Midwest; To Power Pennsylvania Data Center, Add Grid Hardening

0 · Reply

darkflow87 Aug. 21 at 9:40 AM

$CLVT Clarivate provides essential analytics and intellectual property data. Struggling with high debt and integration of past acquisitions. Management's turnaround plan focuses on organic growth; execution risk is high. A show-me story.

0 · Reply

Thestocktraderhubzee Aug. 15 at 9:38 AM

WATCHLIST AUG 15 2025 $LUNR Reuters Reports Intuitive Machines Submits Proposal For NASA's Lunar Terrain Vehicle Delivery And Operations Contract; NASA Is Expected To Announce The LTV Delivery And Demonstration Award By The End Of 2025 $AKRO Akero Publishes 96-Week Phase 2b HARMONY Trial Results In The Lancet Showing Near Complete MASH Reversal In One-Third Of Patients On 50mg EFX $LCID Lucid Unveils Gravity X Concept, A SUV Based On Gravity Grand Touring, Debuting Aug. 17 At Pebble Beach Concours $LIXT LIXTE Biotech Expects 2H 2025 Readouts From Phase 1B/2 Trials Of LB-100 In Ovarian Clear Cell Carcinoma, Soft Tissue Sarcoma, And MSS Colon Cancer $CLVT Clarivate Partners With University Of Melbourne To Implement Alma, Primo, Leganto, Rapido, And Open Workflows, Enhancing Library Systems And User Experience

0 · Reply

FreeBeerTomorrow Aug. 14 at 7:49 AM

$CLVT Clarivate Launches AI-powered Regulatory Assistant Within Cortellis Suite to Boost Productivity and Ease Regulatory Burden

0 · Reply

topstockalerts Jul. 30 at 1:13 PM

$CLVT following closely

0 · Reply

Stock_Catcher Jul. 30 at 12:59 PM

$CLVT thin

1 · Reply

DonCorleone77 Jul. 30 at 10:32 AM

$CLVT Clarivate reports Q2 adjusted EPS 18c, consensus 17c -- Q2 revenue $621.4M, consensus $589.36M. -- Backs FY25 adjusted EPS view 60c-70c, consensus 65 -- Backs FY25 revenue view $2.28B-$2.4B, consensus $2.36B.

0 · Reply

JarvisFlow Jul. 18 at 12:00 PM

Jefferies has adjusted their stance on Clarivate ( $CLVT ), setting the rating to Hold with a target price of 5.2 → 4.5.

0 · Reply

ils85 Jul. 3 at 4:11 PM

$CLVT adding

0 · Reply

Clarivate Plc (CLVT) Presents At Goldman Sachs Communacopia + Technology Conference 2025 Transcript

Sep 4, 2025, 8:00 AM EDT - 10 days ago

Clarivate to Present at the Goldman Sachs Communacopia + Technology Conference on September 11

Aug 27, 2025, 3:00 AM EDT - 18 days ago

Sinopec Group Selects Clarivate for Impactful Research and Innovation

Aug 14, 2025, 10:00 PM EDT - 4 weeks ago

Clarivate Partners with the University of Melbourne to Transform Library Systems

Aug 14, 2025, 3:00 AM EDT - 4 weeks ago

Clarivate Launches AI-powered Regulatory Assistant Within Cortellis Suite to Boost Productivity and Ease Regulatory Burden

Aug 8, 2025, 7:30 AM EDT - 5 weeks ago

Clarivate to Present at the Oppenheimer 28th Annual Technology, Internet & Communications Virtual Conference on August 13

Aug 6, 2025, 6:21 AM EDT - 5 weeks ago

Clarivate Plc: Turnaround In Progress, But Is It Worth The Wait?

Aug 1, 2025, 9:27 AM EDT - 6 weeks ago

Clarivate: Upside Is Attractive If Execution Holds

Jul 30, 2025, 12:16 PM EDT - 6 weeks ago

Clarivate Plc (CLVT) Q2 2025 Earnings Call Transcript

Jul 30, 2025, 6:01 AM EDT - 6 weeks ago

Clarivate Announces Maroun S. Mourad as President, Intellectual Property

Jul 30, 2025, 6:00 AM EDT - 6 weeks ago

Clarivate Reports Second Quarter 2025 Results

Jul 9, 2025, 3:29 AM EDT - 2 months ago

Clarivate Releases 2025 G20 Research and Innovation Scorecard Highlighting Global Collaboration and Impact

Jul 8, 2025, 7:30 AM EDT - 2 months ago

Clarivate to Report Second Quarter 2025 Results on July 30, 2025

Jun 18, 2025, 3:00 AM EDT - 3 months ago

Clarivate Unveils the 2025 Journal Citation Reports

Jun 16, 2025, 4:00 AM EDT - 3 months ago

Clarivate Identifies Radioligand Therapy Innovators as Companies to Watch in the Future of Precision Oncology

Jun 9, 2025, 3:00 AM EDT - 3 months ago

Clarivate Partners with American Library Association to Advocate for U.S. Libraries

Jun 3, 2025, 3:00 AM EDT - 3 months ago

Clarivate Partners with CRKN to Further Canada's Research Goals

Jun 2, 2025, 8:30 AM EDT - 3 months ago

Clarivate Completes Refinancing of Majority of Senior Secured Notes Due 2026

Jun 2, 2025, 3:00 AM EDT - 3 months ago

Clarivate and CAPES Expand Landmark Partnership to Power Research and Innovation Across Brazil

May 19, 2025, 3:00 AM EDT - 4 months ago

Clarivate Launches AI-based RiskMark to Accelerate Trademark Conflict Assessments

May 15, 2025, 3:00 AM EDT - 4 months ago

Clarivate Report Reveals Top Trademark Portfolios

May 14, 2025, 4:00 AM EDT - 4 months ago

Clarivate Enhances OFF-X with Pathway Maps to Accelerate Target Safety Assessments

May 3, 2025, 4:33 AM EDT - 4 months ago

Clarivate: Organic Growth Has Reached A Potential Inflection Point

Apr 29, 2025, 1:09 PM EDT - 4 months ago

Clarivate Plc (CLVT) Q1 2025 Earnings Call Transcript

Apr 29, 2025, 6:00 AM EDT - 4 months ago

Clarivate Reports First Quarter 2025 Results

Apr 23, 2025, 4:00 AM EDT - 5 months ago

Clarivate Launches DRG Commercial Analytics 360 Enabling Medtech Companies to Advance Commercial Strategy and Execution

Apr 23, 2025, 3:00 AM EDT - 5 months ago

Clarivate Releases EndNote 2025 with AI-Powered Research Tools

Apr 2, 2025, 8:05 AM EDT - 5 months ago

Clarivate to Report First Quarter 2025 Results on April 29, 2025

Mar 18, 2025, 4:00 AM EDT - 6 months ago

Clarivate Partners with Iprova to Streamline the Invention Creation and Submission Process

Mar 12, 2025, 4:00 AM EDT - 6 months ago

Clarivate Reveals Top 100 Global Innovators 2025

Feb 27, 2025, 3:00 AM EST - 7 months ago

Clarivate Report Explores Opportunities for Innovation and Market Expansion in Latin America

Feb 19, 2025, 3:55 PM EST - 7 months ago

Clarivate Plc (CLVT) Q4 2024 Earnings Call Transcript

Feb 19, 2025, 6:00 AM EST - 7 months ago

Clarivate Reports Fourth Quarter and Full Year 2024 Results

Feb 18, 2025, 3:00 AM EST - 7 months ago

Clarivate Unveils Transformative Subscription-Based Access Strategy for Academia

Feb 10, 2025, 9:30 AM EST - 7 months ago

Clarivate Recognized for Excellence in Trademark Business in the WTR 1000 2025

Feb 5, 2025, 3:00 AM EST - 7 months ago

Clarivate Selected by National and University Library in Zagreb, Croatia to Create a Unified National Library Platform

Feb 4, 2025, 3:00 AM EST - 7 months ago

Clarivate Reveals Medtech Breakthroughs Driving Growth in Pulsed Field Ablation Market

Jan 30, 2025, 3:00 AM EST - 8 months ago

Clarivate identifies top 50 universities powering global innovation

Jan 28, 2025, 3:00 AM EST - 8 months ago

The British Library Selects Clarivate to Provide Library Services and Discovery Platforms

Jan 22, 2025, 8:45 AM EST - 8 months ago

Clarivate to Report Fourth Quarter and Full Year 2024 Results on February 19, 2025

Jan 16, 2025, 3:00 AM EST - 8 months ago

BioWorld by Clarivate Releases Comprehensive 2024 Year in Review

Jan 14, 2025, 11:40 AM EST - 8 months ago

Post-marketing Pharmacovigilance and Medical Information Market Research 2024: Rising Adverse Drug Reactions (ADRs) and Expanding Use of Biologics and Specialty Drugs Fueling Growth - Forecast to 2034

Jan 14, 2025, 3:10 AM EST - 8 months ago

Clarivate Launches DRG Fusion - A New Life Sciences Analytics Product Powered by Real-World Data

Jan 8, 2025, 3:05 AM EST - 8 months ago

Clarivate Identifies Eleven Potential Blockbuster and Transformative Drugs in Annual Drugs to Watch Report

Dec 16, 2024, 8:00 AM EST - 9 months ago

Clarivate Announces New $500 Million Share Repurchase Authorization

Dec 12, 2024, 3:00 AM EST - 9 months ago

Clarivate Launches AI-Powered Patent Search Solution in Derwent

Nov 27, 2024, 8:00 AM EST - 10 months ago

Clarivate and the Chinese Academy of Sciences Release Annual Collaborative Report to Identify 125 Research Fronts

Nov 27, 2024, 3:00 AM EST - 10 months ago

Daikin Selects IPfolio from Clarivate

Nov 21, 2024, 3:00 AM EST - 10 months ago

BioWorld by Clarivate Highlights Gaps in Women's Health Research and Investment in New Special Series

Nov 19, 2024, 3:00 AM EST - 10 months ago

Clarivate Reveals Highly Cited Researchers 2024 List

briefingcom Aug. 27 at 1:02 PM

0 · Reply

Thestocktraderhubzee Aug. 27 at 10:02 AM

0 · Reply

darkflow87 Aug. 21 at 9:40 AM

0 · Reply

Thestocktraderhubzee Aug. 15 at 9:38 AM

0 · Reply

FreeBeerTomorrow Aug. 14 at 7:49 AM

$CLVT Clarivate Launches AI-powered Regulatory Assistant Within Cortellis Suite to Boost Productivity and Ease Regulatory Burden

0 · Reply

topstockalerts Jul. 30 at 1:13 PM

$CLVT following closely

0 · Reply

Stock_Catcher Jul. 30 at 12:59 PM

$CLVT thin

1 · Reply

DonCorleone77 Jul. 30 at 10:32 AM

0 · Reply

JarvisFlow Jul. 18 at 12:00 PM

Jefferies has adjusted their stance on Clarivate ( $CLVT ), setting the rating to Hold with a target price of 5.2 → 4.5.

0 · Reply

ils85 Jul. 3 at 4:11 PM

$CLVT adding

0 · Reply

smartkarma Jun. 26 at 10:04 PM

$CLVT | Clarivate Plc: Will The Management Focus On A Subscription-First Model Deliver Solid Growth? "Clarivate's first quarter of 2025 showed a mix of strategic advancements and financial performance amid an evolving business landscape. The..." - Baptista Research (Baptista Research) Read more: https://www.smartkarma.com/insights/clarivate-plc-will-the-management-focus-on-a-subscription-first-model-deliver-solid-growth

0 · Reply

NewsAndFilings Jun. 16 at 1:19 PM

$SNYR $PSHG $CLVT $BTG 10 Most Undervalued Stocks to Buy for Under $5 https://www.insidermonkey.com/blog/10-most-undervalued-stocks-to-buy-for-under-5-1552667/

0 · Reply

Thestocktraderhubzee Jun. 9 at 9:35 AM

WATCHLIST JUN 09 2025 $NTHI NeOnc Technologies Says USC Brain Tumor Authority To Accelerate Four Clinical Trials Including Lead Asset NEO100 Nearing Phase 2a Completion Ahead Of Schedule $DOCU B of A Securities Maintains Neutral on Docusign, Lowers Price Target to $85 $ADVB Advanced Biomed Enters Purchase Agreement With Helena Global; To Issue And Sell Up To $25M In Common Stock $CLVT Clarivate Deepens Longstanding Partnership With American Library Association By Supporting Public Advocacy Through 2027 $HBAN Argent Institutional Trust Company Agrees To Acquire Corporate Trust And Institutional Custody Business Of Huntington National Bank; Terms Not Disclosed

0 · Reply

Estimize Jun. 3 at 11:00 AM

Wall St is expecting 0.17 EPS for $CLVT Q2 [Reporting 07/31 BMO] http://www.estimize.com/intro/clvt?chart=historical&metric_name=eps&utm_co

0 · Reply

DonCorleone77 Jun. 3 at 10:21 AM

$CLVT Clarivate enters multi-year pact with Canadian Research Knowledge Network Clarivate announced a multi-year partnership with the Canadian Research Knowledge Network, a consortium of libraries and research institutions in Canada. The agreement provides 55 Canadian universities with expanded access to the Web of Science and is designed to enhance inter-member research collaborations, improving accessibility to Web of Science content for all members.

0 · Reply

DonCorleone77 Jun. 2 at 10:43 AM

$CLVT Clarivate renews multi-year partnership with CAPES Clarivate announced the renewal of its multi-year partnership with CAPES, significantly expanding access to trusted Academia & Government and Life Sciences & Healthcare data across over 400 Brazilian institutions. As compared to the previous contract, the agreement increases institutional coverage by 57%, extending the reach of high-quality research tools to universities and research centers across Brazil - from major metropolitan areas to the country's most remote regions.

0 · Reply

Estimize May. 12 at 11:03 AM

Wall St is expecting 0.17 EPS for $CLVT Q2 [Reporting 07/31 BMO] http://www.estimize.com/intro/clvt?chart=historical&metric_name=eps&utm_co

0 · Reply

CoffeeInTheSnow Apr. 29 at 3:57 PM

$CLVT

0 · Reply

UnicornPicks Apr. 29 at 2:11 PM

Not much ideas this morning $SAGT $CLVT since we're more focused on the $QQQ play.

0 · Reply

HaltTradeAlert Apr. 29 at 1:37 PM

$CLVT Halt Time: 09:35:48 Issue Symbol: CLVT Reason Code: M Members get this halt alert with no delay and with more info: last stock price, volume, shares outstanding, market cap, relative volume, and percentage change on the day. Also, halt alerts for pre-market hours and after market hours which is extremely important for Code T1 News Pending Alerts!! And free real time news catalyst alerts!

0 · Reply

halted_stocks Apr. 29 at 1:37 PM

0 · Reply

Estimize Apr. 29 at 11:06 AM

$CLVT reported - EPS and - revenue for Q1. http://www.estimize.com/intro/clvt?chart=historical&metric_name=eps&utm_content=CLVT&utm_medium=

0 · Reply

Market Cap	2.88B
Revenue (ttm)	2.56B
Net Income (ttm)	-636.70M
EPS (ttm)	N/A
PE Ratio	6.94
Forward PE	8.06
Profit Margin	-24.90%
Debt to Equity Ratio	0.90

Volume	2,018,600
Avg Vol	4,236,048
Day's Range	N/A - N/A
Shares Out	672.22M
Stochastic %K	42%
Beta	1.40
Analysts	Sell
Price Target	$5.26